Market Overview
The South America mammography market covers analog, digital, and 3D breast imaging systems alongside associated services across Latin American economies. Valued at roughly $2.8 billion in 2025, it is one of the faster-growing segments within the regional diagnostic imaging industry. Market expansion reflects both rising breast cancer awareness and steady modernization of public health infrastructure.
- •Market value around $2.8 billion in 2025 with an ~8.5% CAGR projection
- •Brazil, Mexico, Argentina, and Chile account for the largest share of regional demand
- •Transition from analog to full-field digital and digital breast tomosynthesis systems is reshaping equipment sales
Growth Drivers
Rising breast cancer incidence and earlier screening recommendations are expanding the addressable patient population across major Latin American markets. Public investment in cancer control programs, combined with growing private-sector healthcare capacity, is accelerating equipment procurement. The adoption of AI-assisted image analysis is improving throughput and supporting broader deployment in mid-sized facilities.
- •Breast cancer remains the most commonly diagnosed cancer among women in the region, driving screening demand
- •Government financing initiatives and national cancer plans are expanding public screening access
- •AI and digital workflow upgrades are improving diagnostic efficiency and equipment utilization
Segmentation and Regional Analysis
The market segments across product type (analog, digital, 3D tomosynthesis), end-user (hospitals, diagnostic centers, ambulatory clinics), and geography. Brazil leads regional consumption due to the size of its public health system and ongoing SUS-led screening initiatives. Mexico, Argentina, Colombia, and Chile represent the next tier of demand, supported by growing private imaging networks and rising healthcare expenditure per capita.
- •Hospitals and diagnostic imaging centers represent the dominant end-user segment
- •Digital mammography systems account for the largest revenue share, with 3D tomosynthesis the fastest-growing sub-segment
- •Urban centers lead adoption, while rural and northern regions of Brazil and the Andean countries remain underserved
Trends and Outlook
What are the recent trends and outlook?
Through 2030, the market is expected to benefit from continued migration toward digital and 3D platforms, broader AI integration, and expansion of population-based screening programs. Reimbursement reform and public-private partnerships will be key to unlocking growth in lower-income markets. Despite this trajectory, structural barriers including workforce shortages, infrastructure gaps, and uneven reimbursement will continue to moderate the pace of expansion.
- •AI-enabled mammography and tomosynthesis adoption are expected to accelerate through the late 2020s
- •Public-private partnerships and national screening scale-ups are likely to drive equipment volume in Brazil and the Andean region
- •Workforce capacity gaps and reimbursement inconsistencies remain the principal headwinds to faster market growth
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.